Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

11
Number of overlapping holdings
18.0%
% of XLV's 61 holdings also in MEDX
36.7%
% of MEDX's 30 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.9% | 16.8% | 11.9% | |
ABBVIE INC | 6.1% | 8.7% | 6.1% | |
JOHNSON & JOHNSON | 6.8% | 4.8% | 4.8% | |
MERCK & CO. INC. | 4.7% | 4.1% | 4.1% | |
AMGEN INC | 2.9% | 5.9% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to MEDX
UNITEDHEALTH GROUP INC | 9.3% | |
THERMO FISHER SCIENTIFIC INC | 4.3% | |
ABBOTT LABORATORIES | 4.1% | |
INTUITIVE SURGICAL INC | 3.8% | |
BOSTON SCIENTIFIC CORP | 2.8% | |
DANAHER CORP | 2.7% | |
STRYKER CORP | 2.5% | |
GILEAD SCIENCES INC | 2.3% | |
VERTEX PHARMACEUTICALS INC | 2.2% | |
MEDTRONIC PLC | 2.2% |
XLV Underweight Relative to MEDX
NOVARTIS AG-ADR | -6.2% | |
ASTRAZENECA PLC-SPONS ADR | -5.4% | |
ELI LILLY & CO | -4.9% | |
ALNYLAM PHARMACEUTICALS INC | -4.8% | |
ALKERMES PLC | -4.5% | |
BRISTOL-MYERS SQUIBB CO | -4.2% | |
AMGEN INC | -3.0% | |
CRISPR THERAPEUTICS AG | -2.7% | |
ABBVIE INC | -2.6% | |
IONIS PHARMACEUTICALS, INC. | -2.4% |